Key indicators: single-crystal X-ray study; T = 295 K; mean (C-C) = 0.002 Å; R factor = 0.047; wR factor = 0.139; data-to-parameter ratio = 20.3. organic compounds o674 Dardouri et al.
The seven-membered ring of the title compound, C 25 H 40 N 2 O 2 , adopts a boat-shaped conformation (with the C atoms of the fused-ring as the stern and the methine C atom as the prow). The tetradecyl substituent occupies an equatorial position, with the tetradodecyl chain exhibibiting an an all-trans conformation.
Related literature
For the crystal structure of the 12-bromododecyl-substituted analog, see: Dardouri et al. (2010) .
Experimental
Crystal data C 25 H 40 N 2 O 2 M r = 400.59 Monoclinic, P2 1 =c a = 8.1286 (1) Å b = 33.5899 (5) Å c = 9.4095 (2) Å = 114.640 (1) V = 2335.22 (7) Å 3 Z = 4 Mo K radiation = 0.07 mm À1 T = 295 K 0.20 Â 0.02 Â 0.02 mm
Data collection
Bruker X8 APEXII diffractometer 29471 measured reflections 5359 independent reflections 3671 reflections with I > 2(I) R int = 0.044 Refinement R[F 2 > 2(F 2 )] = 0.047 wR(F 2 ) = 0.139 S = 1.03 5359 reflections 264 parameters H-atom parameters constrained Á max = 0.23 e Å À3 Á min = À0.19 e Å À3 Data collection: APEX2 (Bruker, 2008); cell refinement: SAINT (Bruker, 2008); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-SEED (Barbour, 2001); software used to prepare material for publication: publCIF (Westrip, 2010).
form 3-substituted derivatives. In a previous study, the compound was reacted with 1,12-dibromododecane to give the 12-bromododecyl substitued derivative (Dardouri et al., 2010) . The corresponding tetradecyl title compound (Scheme I, Fig. 1 ) was obtained by using 1-bromotetradecane.
Experimental
To a solution of the potassium t-butoxide (0.42 g, 3.6 mmol) in DMF (15 ml) was added 1,5-dimethyl-1,5-benzodiazepine-2,4-dione (0.50 g, 2.4 mmol) and 1-bromotetradecane (0.78 ml, 2.88 mmol). Stirring was continued for 24 h. The reaction was monitored by thin layer ch romatography. The mixture was filtered and the solution evaporated to give colorless crystals.
Refinement
H-atoms were placed in calculated positions (C-H 0.93-0.97 Å) and were included in the refinement in the riding model approximation, with U(H) set to 1.2-1.5U eq (C). 1,3-Dimethyl-3-tetradecyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione (5) O2 0.0396 (7) 0.0461 (7) 0.0365 (6) 0.0029 (5) 0.0229 (5) 0.0055 (5) N1 0.0229 (7) 0.0311 (7) 0.0305 (7) 0.0021 (5) 0.0099 (5) 0.0082 (5) N2 0.0206 (6) 0.0278 (6) 0.0359 (7) 0.0023 (5) 0.0121 (5) 0.0007 (5) (9) 0.0025 (7) −0.0001 (7) 0.0024 (7) C6 0.0271 (8) 0.0216 (7) 0.0307 (8) 0.0058 (6) 0.0071 (6) 0.0013 (6) C7 0.0248 (8) 0.0240 (7) 0.0300 (7) −0.0013 (6) 0.0119 (6) −0.0012 (6) C8 0.0242 (8) 0.0260 (7) 0.0213 (7) 0.0034 (6) 0.0090 (6) 0.0018 (6) C9 0.0225 (8) 0.0300 (8) 0.0250 (7) 0.0041 (6) 0.0115 (6) 0.0013 (6) C10 0.0275 (9) 0.0382 (9) 0.0611 (11) 0.0025 (7) 0.0227 (8) 0.0008 (8) C11 0.0305 (9) 0.0395 (9) 0.0488 (10) −0.0003 (7) 0.0182 (8) (7) 0.0114 (7) 0.0043 (6) C20 0.0301 (9) 0.0368 (9) 0.0330 (8) 0.0081 (7) 0.0138 (7) 0.0071 (7) C21 0.0312 (9) 0.0366 (9) 0.0308 (8) 0.0079 (7) 0.0117 (7) 0.0041 (7) C22 0.0300 (9) 0.0345 (8) 0.0323 (8) 0.0069 (7) 0.0130 (7) 0.0046 (7) C23 0.0319 (9) 0.0343 (8) 0.0345 (8) 0.0079 (7) 0.0149 (7) 0.0051 (7) C24 0.0284 (8) 0.0312 (8) 0.0399 (9) 0.0024 (7) 0.0091 (7) 0.0006 (7) C25 0.0388 (11) 0.0557 (12) 0.0656 (13) 0.0178 (9) 0.0169 (10) 0.0056 (10) Geometric parameters (Å, °) (17) C16-C17-C18 113.44 (13) C4-C3-H3 120.1 C16-C17-H17A 108.9 C2-C3-H3 120.1 C18-C17-H17A 108.9 C3-C4-C5 120.19 (16) C16-C17-H17B 108.9 C3-C4-H4 119.9 C18-C17-H17B 108.9 C5-C4-H4 119.9 H17A-C17-H17B 107.7 C4-C5-C6 120.97 (18) C19-C18-C17 113.73 (13) C4-C5-H5 119.5 C19-C18-H18A 108.8 C6-C5-H5 119.5 C17-C18-H18A 108.8 C1-C6-C5 118.59 (15) C19-C18-H18B 108.8 C1-C6-N2 122.00 (13) C17-C18-H18B 108.8 C5-C6-N2 119.39 (15) H18A-C18-H18B 107.7 O2-C7-N2 121.93 (14) C18-C19-C20 113.43 (13) O2-C7-C8 122.37 (13) C18-C19-H19A 108.9
